Candidate Strain Safety and Translocation Risk
For an immunocompromised host context, prioritize identity, traceability, pathogen screening and tolerance limits before efficacy testing. Assess epithelial crossing, bloodstream-exposure risk proxies and inflammatory responses rather than assuming all candidate probiotics are low risk. Apply biological safety testing and dilution-method antimicrobial susceptibility testing with strain-specific interpretation.
Decision output: candidate risk matrix, susceptibility profile and go/no-go criteria.

